We’ve been fixing data workflows since the Space Odyssey
If there’s somethin’ strange in your… dataset. Who you gonna call? While we typically don’t spend our time chasing ghosts in machines, we do have more than 20 years of experience in busting very complex data-focused problems in and around pre-clinical drug discovery. In other words: We’ve seen most problems and figured out how to solve them. So whether you need domain experts to run your next project or hands on coding and integrating advanced robots, software, or the like, grit42 can get the job done. Just like we have for companies like Novozymes, Sanofi, Lundbeck Pharma, Roche, LEO Pharma, the Gates Foundation, Ferring Pharma, and multiple EU-backed projects within Anti-Microbial Resistance.
Modular end-to-end drug discovery platform
Most pre-clinical drug discovery entities use a combination of an electronic lab notebook, equipment software, data warehouse, lab logistics software, visualization tools, and a lot of manual data analyses using spreadsheets. With grit42’s platform, you get all of that combined in to one user-friendly web-based package, seamlessly integrated using FAIR principles, and with a fully documented API. That means our digital laboratory infrastructure provides a scientific data management platform including day-to-day lab workflows, visualizations, and handling compound and sample logistics. Our platform has been designed to be modular and extensible, meaning we’re ready to solve anything from a single disconnected workflow to co-creating your next end-to-end solution. Does it sound too good to be true? It’s not. And it’s already fully operational on multiple customer sites.
If software is hard to work with, how truly useful is it?
We fix broken workflows and help you with this
- Dispose of the infinite copy/paste between spreadsheets and applications
- Facilitate comparisons of new experiments against older – or historic – data
- Eliminate exporting to perform analytics and then re-uploading for storage
- Allow you to perform new analyses on original raw data
- Establish efficient data flows across the domains
Some of our customers…
A straightforward path to insights
We made it our mission to understand what you do
We think software must be user-friendly and intuitive to become successful. So we made it our mission to exactly understand the work that you do. We have done this continually through 15 years of anthropological observations in labs focused on pre-clinical drug discovery.
Software enabling workflows to be reduced from days to minutes
In other words, we have been observing domain experts for years, and subsequently designed the ideal software to support them. Our insights from all these observations, ultimately resulted in experiment centric software, enabling workflows to be reduced from days to minutes – all while being user-friendly, intuitive, and supporting what you’re already doing.
We call it scientific software for humans
Scientific software for humans – made by humans. And Marvin. In other words: We hate software that’s overly complex because no one bothered to actually understand the domain they’re in. So if you’re tired of broken workflows in your software and headaches from endless import – export, we might be your new best friend.
Software for pre-clinical drug discovery
Using our combined 60+ years of experience of managing data, compounds, and test animals at large pharma companies, we made the grit42 platform for data management in pre-clinical drug discovery. From basic idea, to in vitro and in vivo experiments – while monitoring your compounds, data, and results – our platform keeps track of everything. This enables you to focus on the results, visualizations, and ultimately – the insights.
We see a great potential in applying state-of-the-art data management and data integration to leverage our R&D activities and improve our decision making. To strengthen these capabilities, we selected grit42 as our strategic software partner after a thorough evaluation against various competing solutions and we are excited about the impact that this collaboration can offer.